19 Panel Mega Cup - MAM/AMP/BARB/BUP/BZO/COC/FEN/K2/KET/KRA/ mAMP/MDMA/OPI/MTD/OXY/PCP/THC/TRA/ETG +…

The Florida Department of Children and Families issued contract award C7420A on May 18, 2026, for the procurement of drug screening test panels. The contract, valued at $4,516.00, represents the purchase of 50 units of 19-panel mega cup drug testing devices at a unit price of $90.32 each. The mega cup panels are designed to detect the presence of multiple controlled substances and their metabolites, including amphetamine, methamphetamine, barbiturates, benzodiazepines, buprenorphine, benzoylecgonine (cocaine metabolite), fentanyl, K2, ketamine, kratom, methylamphetamine, 3,4-methylenedioxymethamphetamine (MDMA), opiates, methadone, oxycodone, phencyclidine (PCP), tetrahydrocannabinol (THC), tramadol, ethyl glucuronide (ETH), and various adulterants.

The contract period extends from the award date of May 18, 2026, through the completion date of June 30, 2026. While the prime contractor name is not specified in the provided documentation, the contracting organization is the Florida Department of Children and Families. These drug screening test panels would typically support the department's substance abuse screening and monitoring protocols across its service delivery functions.